Verano Holdings (VRNO) Change in Account Payables (2021 - 2026)
Verano Holdings' (VRNO) quarterly Change in Account Payables came in at -$5.7 million in Q1 2026, down 175.52% year-on-year from $7.6 million in Q1 2025, and down 329.87% on a QoQ basis from -$1.3 million in Q4 2025.
Verano Holdings (VRNO) Change in Account Payables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Change in Account Payables data on file, last reported at -$5.7 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 175.52% year-over-year to -$5.7 million in Q1 2026; TTM through Mar 2026 was -$7.9 million, a 206.61% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 228.5% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$5.7 million, down from -$1.3 million in the prior quarter.
- Over the last five years, Change in Account Payables for VRNO reached as high as $19.9 million in Q1 2022 and fell as low as -$13.7 million in Q4 2022.
- Historically, Change in Account Payables has averaged -$1.2 million across 5 years, with a median of -$3.0 million in 2024.
- On a YoY basis, Change in Account Payables climbed as much as 2522.59% in 2024 and fell as far as 495.85% in 2024.
- Year by year, Change in Account Payables stood at -$13.7 million in 2022, then soared by 96.32% to -$506000.0 in 2023, then tumbled by 495.85% to -$3.0 million in 2024, then surged by 55.92% to -$1.3 million in 2025, then slumped by 329.87% to -$5.7 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$5.7 million in Q1 2026, -$1.3 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -5.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.71 Mn |
| Mar 31, 2026 | -5.71 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | -6.21 Mn |
| Jun 30, 2025 | -6.21 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -5.84 Mn |
| Jun 30, 2024 | -5.84 Mn |
| Mar 31, 2024 | -4.03 Mn |
| Mar 31, 2024 | -4.03 Mn |
| Dec 31, 2023 | -506,000.00 |
| Dec 31, 2023 | -506,000.00 |